
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1046 | 1059 | 1130 | 1168 | 1257 | 1711 |
Fund Return | 4.64% | 5.9% | 12.98% | 5.31% | 4.68% | 5.52% |
Place in category | 201 | 192 | 255 | 255 | 216 | 109 |
% in Category | 39 | 41 | 57 | 61 | 56 | 44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Multi Asset Fund IV R3 GBP Acc | 1.12B | 1.61 | 7.99 | 6.83 | ||
International Index Tracking Fund 2 | 833.9M | 0.53 | 12.05 | 11.82 | ||
International Index Tracking Fund 1 | 833.9M | 19.84 | 8.41 | 11.86 | ||
UK Equity Income Fund 2 GBP Acc | 668.3M | 6.09 | 6.65 | 5.62 | ||
UK Equity Income Fund 2 GBP Inc | 668.3M | 7.41 | 3.20 | 5.66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 1.87B | 6.61 | 10.97 | 7.28 | ||
TB Evenlode Income B Income | 2.81B | 3.59 | 6.59 | 7.84 | ||
UK Equity Income Fund Retail Income | 121.54M | 3.04 | 7.62 | 5.96 | ||
UK Equity Income Fund Institutional | 79.66M | 3.09 | 8.21 | 6.55 | ||
UK Equity Income Fund Z Accumulatio | 546.37M | 1.76 | 8.88 | 6.44 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 7.31 | 26.77 | -5.51% | |
Unilever | GB00B10RZP78 | 6.25 | 52.14 | -2.94% | |
National Grid | GB00BDR05C01 | 5.32 | 973.20 | -1.82% | |
AstraZeneca | GB0009895292 | 4.90 | 9,667.0 | -6.82% | |
Lloyds Banking | GB0008706128 | 4.71 | 64.40 | -2.90% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review